Clinical Trial Update: Darbepoetin Alfa With or Without Intravenous (IV) Iron [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated darbepoetin alfa with or without intravenous iron for anemia in patients with non-myeloid malignancies. The study is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Non-myeloid Malignancies

Drugs mentioned

• Darbepoetin alfa (Aranesp) (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Non-Myeloid Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2014-01-29